305 related articles for article (PubMed ID: 18567806)
1. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
Leu FP; Nandi M; Niu C
Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2.
Giannouli CC; Kletsas D
Cell Signal; 2006 Sep; 18(9):1417-29. PubMed ID: 16361081
[TBL] [Abstract][Full Text] [Related]
3. Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.
Ungefroren H; Künstner A; Busch H; Franzenburg S; Luley K; Viol F; Schrader J; Konukiewitz B; Wellner UF; Meyhöfer SM; Keck T; Marquardt JU; Lehnert H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555512
[TBL] [Abstract][Full Text] [Related]
4. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
[TBL] [Abstract][Full Text] [Related]
5. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
[TBL] [Abstract][Full Text] [Related]
6. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model.
Siddique ZL; Drozdov I; Floch J; Gustafsson BI; Stunes K; Pfragner R; Kidd M; Modlin IM
Neuroendocrinology; 2009; 89(4):458-70. PubMed ID: 19295186
[TBL] [Abstract][Full Text] [Related]
7. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
8. Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD.
Ye L; Zhang HY; Wang H; Yang GH; Bu H; Zhang L; Wang SL
Chin Med J (Engl); 2005 Apr; 118(8):678-86. PubMed ID: 15899124
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta control of cell proliferation.
Huang SS; Huang JS
J Cell Biochem; 2005 Oct; 96(3):447-62. PubMed ID: 16088940
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
Woodworth CD; Chung J; McMullin E; Plowman GD; Simpson S; Iglesias M
Cell Growth Differ; 1996 Jun; 7(6):811-20. PubMed ID: 8780894
[TBL] [Abstract][Full Text] [Related]
11. Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures.
Mukherjee A; Dong SS; Clemens T; Alvarez J; Serra R
Mech Dev; 2005 Apr; 122(4):557-71. PubMed ID: 15804568
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
13. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling.
Kong B; Michalski CW; Hong X; Valkovskaya N; Rieder S; Abiatari I; Streit S; Erkan M; Esposito I; Friess H; Kleeff J
Oncogene; 2010 Sep; 29(37):5146-58. PubMed ID: 20581862
[TBL] [Abstract][Full Text] [Related]
14. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.
Soto-Cerrato V; Viñals F; Lambert JR; Pérez-Tomás R
Biochem Pharmacol; 2007 Nov; 74(9):1340-9. PubMed ID: 17765876
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.
Portella G; Cumming SA; Liddell J; Cui W; Ireland H; Akhurst RJ; Balmain A
Cell Growth Differ; 1998 May; 9(5):393-404. PubMed ID: 9607560
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta 1 induces expression of statin during differentiation of human promonocytic leukemia cells.
Ignotz RA
J Cell Biochem; 1992 Nov; 50(3):285-92. PubMed ID: 1469065
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
18. [Functional study on TGF-beta/Smads signaling pathway in human ovarian cancer cells].
Zhang YY; Li X; Sui LH; Wang Q; Li P; Fu SB
Yi Chuan Xue Bao; 2004 Aug; 31(8):759-65. PubMed ID: 15481528
[TBL] [Abstract][Full Text] [Related]
19. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression.
Fischer AN; Fuchs E; Mikula M; Huber H; Beug H; Mikulits W
Oncogene; 2007 May; 26(23):3395-405. PubMed ID: 17130832
[TBL] [Abstract][Full Text] [Related]
20. Smad4-independent TGF-beta signaling in tumor cell migration.
Giehl K; Imamichi Y; Menke A
Cells Tissues Organs; 2007; 185(1-3):123-30. PubMed ID: 17587818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
